Cancer Cell 2017-07-10

Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology

Julian Blagg, Paul Workman

Index: 10.1016/j.ccell.2017.06.005

Full Text: HTML

Abstract

Small-molecule chemical probes or tools have become progressively more important in recent years as valuable reagents to investigate fundamental biological mechanisms and processes causing disease, including cancer. Chemical probes have also achieved greater prominence alongside complementary biological reagents for target validation in drug discovery. However, there is evidence of widespread continuing misuse and promulgation of poor-quality and insufficiently selective chemical probes, perpetuating a worrisome and misleading pollution of the scientific literature. We discuss current challenges with the selection and use of chemical probes, and suggest how biologists can and should be more discriminating in the probes they employ.

Latest Articles:

HDAC Inhibitors Finally Open Up: Chromatin Accessibility Signatures of CTCL

2017-07-10

[10.1016/j.ccell.2017.06.008]

Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and CHAARTED Studies

2017-07-10

[10.1016/j.ccell.2017.06.007]

MUC-king with HIF May Rewire Pyrimidine Biosynthesis and Curb Gemcitabine Resistance in Pancreatic Cancer

2017-07-10

[10.1016/j.ccell.2017.06.006]

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer

2017-07-10

[10.1016/j.ccell.2017.06.004]

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment

2017-07-10

[10.1016/j.ccell.2017.06.003]

More Articles...